Literature DB >> 27825571

Frequency of reactive arthritis, uveitis, and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy: A 20-year, two-centre retrospective study.

Yoshinori Taniguchi1, Hirofumi Nishikawa2, Takashi Karashima3, Yasuhiko Yoshinaga4, Shimpei Fujimoto2, Yoshio Terada2.   

Abstract

Entities:  

Keywords:  BCG; Bladder cancer; Conjunctivitis; HLA; Reactive arthritis; Uveitis

Mesh：

Substances：

Year:  2016        PMID： 27825571     DOI： 10.1016/j.jbspin.2016.09.014

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction.

Authors:  Douglas C Cheung; Alexandra L Millman; Robert J Hamilton
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

2.  Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer.

Authors:  Hitoshi Yoshimura; Tadashi Okano; Kentaro Inui; Hiroaki Nakamura
Journal:  J Med Ultrason (2001)       Date:  2018-07-10       Impact factor: 1.314

Review 3.  Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet's disease, and iBCG-induced ReA.

Authors:  Yoshinori Taniguchi; Hirofumi Nishikawa; Takeshi Yoshida; Yoshio Terada; Kurisu Tada; Naoto Tamura; Shigeto Kobayashi
Journal:  Rheumatol Int       Date:  2021-05-01       Impact factor: 2.631

4.  Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy.

Authors:  Yoshinori Taniguchi; Hirofumi Nishikawa; Takahito Kimata; Yasuhiko Yoshinaga; Shigeto Kobayashi; Yoshio Terada
Journal:  J Clin Rheumatol       Date:  2022-03-01       Impact factor: 3.902
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.